Jackson Grant Investment Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.01K | Hold |
18
| – | – | ﹤0.01% | 280 |
|
2025
Q1 | $8.73K | Hold |
18
| – | – | ﹤0.01% | 271 |
|
2024
Q4 | $7.25K | Hold |
18
| – | – | ﹤0.01% | 288 |
|
2024
Q3 | $8.37K | Hold |
18
| – | – | ﹤0.01% | 277 |
|
2024
Q2 | $8.44K | Hold |
18
| – | – | ﹤0.01% | 276 |
|
2024
Q1 | $7.52K | Hold |
18
| – | – | ﹤0.01% | 271 |
|
2023
Q4 | $7.32K | Hold |
18
| – | – | ﹤0.01% | 268 |
|
2023
Q3 | $6.26K | Hold |
18
| – | – | ﹤0.01% | 274 |
|
2023
Q2 | $6.33K | Hold |
18
| – | – | ﹤0.01% | 279 |
|
2023
Q1 | $5.67K | Buy |
+18
| New | +$5.67K | ﹤0.01% | 316 |
|
2021
Q3 | – | Sell |
-67
| Closed | -$14K | – | 376 |
|
2021
Q2 | $14K | Sell |
67
-49
| -42% | -$10.2K | 0.01% | 330 |
|
2021
Q1 | $25K | Buy |
+116
| New | +$25K | 0.01% | 266 |
|